Carter Melody C, Park Jane, Vadas Peter, Worm Margitta
Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Division of Clinical Immunology and Allergy, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
J Allergy Clin Immunol Pract. 2023 Jul;11(7):1998-2006. doi: 10.1016/j.jaip.2023.05.015. Epub 2023 May 24.
The severity of anaphylaxis is determined by many factors. The allergenic source as well as the age of the affected individual and the route of allergen exposure encompass the major contributors of the clinical outcome. Moreover, the severity can be modulated further by intrinsic and extrinsic factors. Among these, the genetic predisposition, certain comorbidities such as uncontrolled asthma, and hormonal fluctuations have been proposed as intrinsic and antihypertensive medications or physical activity as extrinsic factors. Recent advances have highlighted immunologic pathways that may exacerbate the response to allergens through receptors on mast cells, basophils, platelets, and other granulocytes. Atopy, platelet-activating factor acetylhydrolase deficiency, hereditary alpha tryptasemia, and clonal mast cell disorders are examples associated with genetic alterations that may predispose to severe anaphylaxis. Identifying risk factors that lower the threshold of reactivity or increase the severity of multisystem reactions is important in the management of this patient population.
过敏反应的严重程度由多种因素决定。过敏原来源、受影响个体的年龄以及过敏原暴露途径是临床结果的主要影响因素。此外,严重程度还可由内在和外在因素进一步调节。其中,遗传易感性、某些合并症(如未控制的哮喘)和激素波动被认为是内在因素,而抗高血压药物或体育活动则被认为是外在因素。最近的进展突出了免疫途径,这些途径可能通过肥大细胞、嗜碱性粒细胞、血小板和其他粒细胞上的受体加剧对过敏原的反应。特应性、血小板活化因子乙酰水解酶缺乏症、遗传性α-类胰蛋白酶血症和克隆性肥大细胞疾病是与可能易导致严重过敏反应的基因改变相关的例子。识别降低反应阈值或增加多系统反应严重程度的危险因素对于管理这一患者群体很重要。